SaraSaberiMD
Cardiology • Ann Arbor, MIAdult Congenital Heart Disease, Cardiac Electrophysiology, Echocardiography, Cardiovascular Disease Genetics
Physician
Dr. Saberi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1500 East Medical Center Dr
3rd Floor Cardiovascular Center
Ann Arbor, MI 48109Phone+1 888-287-1082- Is this information wrong?
Education & Training
University of Michigan Health SystemFellowship, Cardiovascular Disease, 2007 - 2010- University of Michigan Health SystemResidency, Internal Medicine, 2003 - 2006
Wayne State University School of MedicineClass of 2003
Certifications & Licensure
MI State Medical License 2003 - 2025- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Study of Exercise Training in Hypertrophic Cardiomyopathy Start of enrollment: 2010 Apr 01
Publications & Presentations
PubMed
- Efficacy and Safety of Aficamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4.Ahmad Masri, Mark V Sherrid, Theodore P Abraham, Lubna Choudhury, Pablo Garcia-Pavia, Christopher M Kramer, Roberto Barriales-Villa, Anjali T Owens, Florian Rader, She...> ;Journal of Cardiac Failure. 2024 Mar 15
- 6 citationsMavacamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results From the MAVA-LTE Study, EXPLORER-LTE Cohort.Rader, F., Oręziak, A., Choudhury, L., Saberi, S., Fermin, D., Wheeler, M., Abraham, T., Garcia-Pavia, P., Zwas, D., Masri, A., Owens, A., Hegde, S., Seidler, T., Fox,...> ;JACC. Heart Failure. 2024 Jan 1
- Mavacamten for Obstructive Hypertrophic Cardiomyopathy With or Without Hypertension: Post-Hoc Analysis of the EXPLORER-HCM Trial.Andrew Wang, John A Spertus, Daniel M Wojdyla, Theodore P Abraham, Ester Kim Nilles, Anjali Tiku Owens, Sara Saberi, Sharon Cresci, Amy Sehnert, Neal K Lakdawala> ;JACC. Heart Failure. 2024 Mar 1
- Join now to see all
Journal Articles
- Exercise Hemodynamics in Hypertrophic Cardiomyopathy Identify Risk of Incident Heart Failure but Not Ventricular Arrhythmias or Sudden Cardiac Death☆Sharlene M Day, Sara Saberi, International Journal of Cardiology
Press Mentions
Cytokinetics Presents Positive Results from Cohort 4 of REDWOOD-HCM and Long-Term Results from FOREST-HCM at the American College of Cardiology 72nd Annual Scientific SessionMarch 4th, 2023- REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health StatusOctober 7th, 2022
- FDA Approves Camzyos for the Treatment of Obstructive Hypertrophic CardiomyopathyMay 6th, 2022
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
University of Michigan Medical CenterAnn Arbor, Michigan
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
